RGEN FY 2018 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$194M+37.4% YoY

Gross Profit

$108M55.7% margin

Operating Income

$26M13.4% margin

Net Income

$17M8.6% margin

EPS (Diluted)

$0.37

Cash Flow

Operating Cash Flow

$33M

Free Cash Flow

$19M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$139M

Total Liabilities

$159M

Stockholders' Equity

$616M

Cash & Equivalents

$194M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$194M	$141M	+37.4%
Gross Profit	$108M	$74M	+45.7%
Operating Income	$26M	$14M	+85.6%
Net Income	$17M	$28M	-41.4%